🇺🇸 FDA
Patent

US 12268777

Compositions and methods for treating eosinophilic disorders

granted A61KA61K31/426A61K31/573

Quick answer

US patent 12268777 (Compositions and methods for treating eosinophilic disorders) held by The Regents of the University of California expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/426, A61K31/573, A61K47/26, A61K47/32